会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • DRIVER SIDE AIRBAG MODULE ASSEMBLY
    • 驾驶员侧面安全气囊组件
    • WO2005118352A2
    • 2005-12-15
    • PCT/US2005017349
    • 2005-05-18
    • AUTOLIV ASP INCWELFORD RICHARD
    • WELFORD RICHARD
    • B60R21/203B60R21/217B60R21/20
    • B60R21/215B60R21/2035B60R21/217
    • An airbag module assembly including a module housing, a door and a door retainer ring. The module housing forms a compartment adapted to contain an inflatable restraint airbag cushion in a stored state. The module housing has at least one open end, and includes at least one side wall and at least one face wall generally perpendicularly disposed relative to the at least one side wall about the at least one open end. The door retainer ring is adapted to be joined to the module housing about the module housing open end. The door includes a circumference portion and has an inner surface and an outer surface. The door, in a static state, is disposed over the module housing to enclose the module housing open end with at least the circumference portion of the door disposed between the door retainer ring and the module housing. The circumference portion of the door includes at least one release portion and at least one hinge section. In the assembly, upon inflation of the inflatable restraint airbag cushion, the inflatable restraint airbag cushion expands against the inner surface of the door, whereby at least the release portion is displaced from between the door retaining ring and the module housing with the door rotatably hinging about the at least one hinge section.
    • 一种安全气囊模块组件,包括模块壳体,门和门保持环。 模块壳体形成适于容纳处于存储状态的可充气约束气囊垫的隔间。 模块壳体具有至少一个开口端,并且包括至少一个侧壁和至少一个面壁,该至少一个面壁相对于至少一个侧壁围绕至少一个开口端大致垂直地设置。 门保持环适合于围绕模块壳体开口端连接到模块壳体。 门包括圆周部分并具有内表面和外表面。 处于静止状态的门被设置在模块壳体上方以将至少设置在门保持环和模块壳体之间的门的周边部分封闭在一起。 门的圆周部分包括至少一个释放部分和至少一个铰链部分。 在组件中,在充气式约束气囊缓冲器膨胀时,充气式约束气囊缓冲件抵靠门的内表面膨胀,由此至少使释放部分从门保持环和模块壳体之间移动,门可旋转地铰接 围绕所述至少一个铰链部分。
    • 4. 发明申请
    • DRIVER SIDE AIRBAG MODULE ASSEMBLY
    • WO2005118352A3
    • 2005-12-15
    • PCT/US2005/017349
    • 2005-05-18
    • AUTOLIV ASP, INC.WELFORD, Richard
    • WELFORD, Richard
    • B60R21/215
    • An airbag module assembly including a module housing, a door and a door retainer ring. The module housing forms a compartment adapted to contain an inflatable restraint airbag cushion in a stored state. The module housing has at least one open end, and includes at least one side wall and at least one face wall generally perpendicularly disposed relative to the at least one side wall about the at least one open end. The door retainer ring is adapted to be joined to the module housing about the module housing open end. The door includes a circumference portion and has an inner surface and an outer surface. The door, in a static state, is disposed over the module housing to enclose the module housing open end with at least the circumference portion of the door disposed between the door retainer ring and the module housing. The circumference portion of the door includes at least one release portion and at least one hinge section. In the assembly, upon inflation of the inflatable restraint airbag cushion, the inflatable restraint airbag cushion expands against the inner surface of the door, whereby at least the release portion is displaced from between the door retaining ring and the module housing with the door rotatably hinging about the at least one hinge section.
    • 5. 发明申请
    • AIRBAG STORAGE SYSTEM
    • 安全气囊储存系统
    • WO2005042316A1
    • 2005-05-12
    • PCT/US2004/034981
    • 2004-10-18
    • AUTOLIV ASP, INCTALLERICO, RogerWELFORD, RichardGAMMILL, Kurt
    • TALLERICO, RogerWELFORD, RichardGAMMILL, Kurt
    • B60R21/16
    • B60R21/231B60R21/201B60R21/2342
    • The cushion retention system (10) includes a cushion (12), at least one tab (16) attached to the cushion (12), and a supporting member (18) having an intermediary region and at least one aperture (34). The cushion (12) is positioned in a folded condition. The supporting member (18) is disposed along an outer periphery of the cushion (12). The tab (16), which includes a head (28) and a narrow neck (29), interlocks with the aperture (34) on the supporting member (18) to retain the supporting member (18) along an outer periphery of the folded cushion (12). In this interlocked condition, the supporting members (18) apply an inward compressive force to retain the cushion (12) in a folded condition.
    • 缓冲保持系统(10)包括缓冲垫(12),附接到缓冲垫(12)的至少一个突舌(16)和具有中间区域和至少一个孔(34)的支撑构件(18)。 衬垫(12)位于折叠状态。 支撑构件(18)沿着衬垫(12)的外周设置。 包括头部(28)和窄颈部(29)的突片(16)与支撑构件(18)上的孔(34)互锁,以沿支撑构件(18)的外周保持支撑构件 缓冲垫(12)。 在该互锁状态下,支撑构件(18)施加向内的压缩力以将缓冲垫(12)保持在折叠状态。
    • 7. 发明申请
    • ANTI-CANCER AGENTS
    • 抗癌药剂
    • WO2004058252A2
    • 2004-07-15
    • PCT/GB2003/005689
    • 2003-12-30
    • ISIS INNOVATION LIMITEDWELFORD, Richard, William, DavidHEWITSON, Kirsty, SarahMCNEILL, Luke, AlexanderSCHOFIELD, Christopher, JosephSCHLEMMINGER, Imre
    • WELFORD, Richard, William, DavidHEWITSON, Kirsty, SarahMCNEILL, Luke, AlexanderSCHOFIELD, Christopher, JosephSCHLEMMINGER, Imre
    • A61K31/4188
    • A61K31/352A61K31/195A61K31/4164A61K31/4188A61K2300/00
    • A pharmaceutical combination which comprises: (a) a compound of one of the formulae: formula (I) wherein each of R I and R II , which max be the same or different, represents hydrogen, fluorine or alkyl of 1 to 6 carbon atoms, X represents CR I R II , NR III or O wherein R III is hydrogen or alkyl of 1 to 6 carbon atoms, each of Y and Z, which may be the same or different, represents hydrogen, NR III , OH or SH, or Y and Z together represents =O or =S, or formula (II) where R 1 to R 11 may independently be H, a branched or straight C 1 to C 6 alkyl chain, OH, O-alkyl having a branched or straight C 1 to C 6 alkyl chain optionally containing 1 or 2 N, O or S atoms, COOH, a branched or straight C 1 to C 6 alkyl ester (alkoxycarbonyl), a 4 to 7 membered heterocyclic ring optionally containing 1 or 2 N, S, O or P atoms or a 5 or 6 membered aromatic ring, optionally containing 1 or more N, O or S atoms, which can be fused to another ring, or a said alkyl chain substituted by a said aromatic ring, and formula (A) represents formula (B) or formula (C) or a pharmaceutically acceptable salt of a said compound; and (b) an anti-cancer alkylating agent. This combination is useful in the treatment of cancer.
    • 一种药物组合,其包含:(a)式(I)之一的化合物,其中R和R II各自相同或不同,表示氢,氟或1至6个碳的烷基 X表示CR R II,NR III或O,其中R III是氢或1至6个碳原子的烷基,Y和Z各自可以相同或不同,表示氢,NR 或者Y和Z一起代表= O或= S,或式(II)其中R 1至R 11可以独立地为H,支链或直链C1至C6烷基链, 具有任选含有1或2个N,O或S原子的支链或直链C 1至C 6烷基链的OH,O-烷基,COOH,支链或直链C1至C6烷基酯(烷氧基羰基),可选地为4至7元杂环 含有1或2个N,S,O或P原子或5或6元芳族环,任选地含有1个或更多个N,O或S原子,其可以与另一个环稠合,或所述烷基链被所述 芳香环, 和式(A)代表式(B)或式(C)或所述化合物的药学上可接受的盐; 和(b)抗癌烷化剂。 这种组合可用于治疗癌症。